Review
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jul 28, 2020; 26(28): 4018-4035
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4018
Figure 1
Figure 1 Optimizing patients with non-alcoholic steatohepatitis cirrhosis for liver transplantation. Patients with non-alcoholic steatohepatitis cirrhosis represent a unique and challenging population. Comorbid conditions which may complicate pre- and post-transplant care are presented along with considerations for optimization. BMI: Body mass index; LT: Liver transplantation; NASH: Non-alcoholic steatohepatitis; HCC: Hepatocellular carcinoma; ESLD: End-stage liver disease; CKD: Chronic kidney disease; SLKT: Simultaneous liver and kidney transplantation.